Tauriga Sciences Inc. to Increase its Marketing Budget to Support the Accelerated Growth in its E-Commerce Business Segment

Rhea-AI Summary

Tauriga Sciences, Inc. (TAUG) announced a significant increase in its marketing budget to boost its high-margin E-Commerce segment, following record-setting sales in Q3 2021. The company has received over 5,300 E-Commerce orders, with growth accelerating, especially in international markets. Additionally, Tauriga's E-Commerce platform now accepts multiple cryptocurrencies, enhancing its global payment options. The company is also making progress on its cannabinoid-based pharmaceutical grade chewing gum and expects to provide shareholders with a material update soon.

Positive

• Planned increase in marketing budget to support growth in high-margin E-Commerce segment.
• Record-setting E-Commerce sales for Q3 2021.
• Over 5,300 E-Commerce orders received, with increasing international orders.
• E-Commerce platform now accepts cryptocurrencies like Bitcoin and Ethereum.

Negative

• None.

New York, NY, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced a planned increase in the Company’s marketing budget, to support the accelerated growth in its highest margin E-Commerce business segment.  The Company generated strong (record setting) E-Commerce sales for its 3^rdFiscal Quarter 2021 (Period: October 1 – December 31, 2020) and is pleased to report that halfway through this current Quarter, growth in its E-Commerce business has continued and accelerated.  The Company is confident about its business prospects for the remainder of calendar 2021 and beyond.  

In other news, the Company has now received more than 5,300 E-Commerce orders and is pleased with the steady increase in international orders.  A major corporate goal of the Company, for calendar year 2021, is to enhance its international presence and business opportunities.  To help achieve this, the Company has successfully configured its E-Commerce Platform to accept the following cryptocurrencies (as payment options): Bitcoin (BTC), Etherium (ETH), Bitcoin Cash (BCH), Dai (DAI), and Litecoin (LTC).

Lastly, the Company continues to realize important progress with respect to the ongoing development of its Cannabinoid-Based Pharmaceutical Grade Chewing Gum.  The Company expects to provide shareholders with a material update, within the near term.

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email: sshaw@tauriga.com

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

FAQ

What is the recent news about Tauriga Sciences, Inc. (TAUG)?

Tauriga Sciences announced a planned increase in its marketing budget to support its growing E-Commerce segment, following record sales in Q3 2021.

How has Tauriga Sciences' E-Commerce performance been recently?

The company has experienced record-setting E-Commerce sales, receiving over 5,300 orders, with accelerated growth especially in international markets.

What payment options has Tauriga Sciences introduced for its E-Commerce platform?

Tauriga now accepts various cryptocurrencies, including Bitcoin, Ethereum, Bitcoin Cash, Dai, and Litecoin as payment options.

What updates are expected from Tauriga Sciences regarding its pharmaceutical development?

Tauriga Sciences is making progress in developing its cannabinoid-based pharmaceutical grade chewing gum and will provide a material update to shareholders soon.